Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma.
10.4166/kjg.2015.66.6.320
- Author:
Oh Sang KWON
1
;
Seong Han CHOI
;
Ju Hyun KIM
Author Information
1. Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Korea. jhkim@gilhospital.com
- Publication Type:Review
- Keywords:
Inflammation;
Fibrosis;
Cirrhosis;
Hepatocellular carcinoma
- MeSH:
Carcinoma, Hepatocellular/*etiology;
Gram-Negative Bacteria/growth & development;
Hepatitis, Chronic/*complications/metabolism/microbiology;
Humans;
Hypoxia;
*Inflammation;
Lipopolysaccharides/metabolism;
Liver/metabolism/pathology;
Liver Cirrhosis/*complications;
Liver Neoplasms/*etiology;
Toll-Like Receptors/metabolism
- From:The Korean Journal of Gastroenterology
2015;66(6):320-324
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Inflammation is one of the most prominent characteristic features of chronic liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Most of HCC cases develop in patients with cirrhosis and cirrhosis develops in patients with chronic liver inflammation. Therefore, there is no doubt that there exist some strong connection among inflammation, fibrosis, and cancer. In fact, chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC. This review will discuss the common mechanism of inflammation and fibrosis in chronic liver diseases, and then demonstrate why HCC develops in inflammatory and fibrotic conditions.
